Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Peterson

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Archives of Pathology & Laboratory Medicine|August 25, 2018
Impact of Molecular Sequencing Information as Related to 2008 and 2016 World Health Organization Classification of Acute Myeloid Leukemia and MyelodysplasiaLaura N Toth, Francine B de Abreu, Jason D Peterson, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation SequencingM Rabie Al-Turkmani, Kelley N Godwin, Jason D Peterson, et al.
Neoplasia (New York, N.Y.)|February 18, 2018
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation SequencingZahra Shajani-Yi, Francine B de Abreu, Jason D Peterson, et al.
Experimental and Molecular Pathology|February 14, 2017
Variant call concordance between two laboratory-developed, solid tumor targeted genomic profiling assays using distinct workflows and sequencing instrumentsKen J Hampel, Francine B de Abreu, Nikoletta Sidiropoulos, et al.
Clinical Chemistry and Laboratory Medicine|February 13, 2016
Effective quality management practices in routine clinical next-generation sequencingFrancine B de Abreu, Jason D Peterson, Christopher I Amos, et al.
Experimental and Molecular Pathology|August 21, 2017
Somatic mutation analysis in melanoma using targeted next generation sequencingAllen P Miraflor, Francine B de Abreu, Jason D Peterson, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2016
The Pitfalls of Companion Diagnostics: Evaluation of Discordant EGFR Mutation Results from a Clinical Laboratory and a Central LaboratoryScott A Turner, Jason D Peterson, Jason R Pettus, et al.
Human Pathology|December 6, 2014
Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinomaKristen E Muller, Laura J Tafe, Francine B de Abreu, et al.
Experimental and Molecular Pathology|July 20, 2015
Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencingJuan Putra, Francine B de Abreu, Jason D Peterson, et al.
Clinical Chemistry and Laboratory Medicine|December 17, 2013
Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutationsGregory J Tsongalis, Jason D Peterson, Francine B de Abreu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Archives of Pathology & Laboratory Medicine|August 25, 2018
Impact of Molecular Sequencing Information as Related to 2008 and 2016 World Health Organization Classification of Acute Myeloid Leukemia and MyelodysplasiaLaura N Toth, Francine B de Abreu, Jason D Peterson, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation SequencingM Rabie Al-Turkmani, Kelley N Godwin, Jason D Peterson, et al.
Neoplasia (New York, N.Y.)|February 18, 2018
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation SequencingZahra Shajani-Yi, Francine B de Abreu, Jason D Peterson, et al.
Experimental and Molecular Pathology|February 14, 2017
Variant call concordance between two laboratory-developed, solid tumor targeted genomic profiling assays using distinct workflows and sequencing instrumentsKen J Hampel, Francine B de Abreu, Nikoletta Sidiropoulos, et al.
Clinical Chemistry and Laboratory Medicine|February 13, 2016
Effective quality management practices in routine clinical next-generation sequencingFrancine B de Abreu, Jason D Peterson, Christopher I Amos, et al.
Experimental and Molecular Pathology|August 21, 2017
Somatic mutation analysis in melanoma using targeted next generation sequencingAllen P Miraflor, Francine B de Abreu, Jason D Peterson, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2016
The Pitfalls of Companion Diagnostics: Evaluation of Discordant EGFR Mutation Results from a Clinical Laboratory and a Central LaboratoryScott A Turner, Jason D Peterson, Jason R Pettus, et al.
Human Pathology|December 6, 2014
Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinomaKristen E Muller, Laura J Tafe, Francine B de Abreu, et al.
Experimental and Molecular Pathology|July 20, 2015
Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencingJuan Putra, Francine B de Abreu, Jason D Peterson, et al.
Clinical Chemistry and Laboratory Medicine|December 17, 2013
Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutationsGregory J Tsongalis, Jason D Peterson, Francine B de Abreu, et al.
Pageof 3